Skip to content

News

Pink Sheet – Accelerated Approval: US FDA Wants Comprehensive Development Plan From Oncology Sponsors

News

Endpoints News – When efficacy is borderline: FDA needs to get more consistent on close-call drug approvals, agency-funded research finds

News

The New England Journal of Medicine – Treatment of Older Adults with Cancer — Addressing Gaps in Evidence

News

Regulatory Focus – Groups suggest changes to FDA’s guidance expanding eligibility criteria for oncology trials

News

OncLive – 3 Precision Era Biomarkers Get a Closer Look

News

STAT News – Will controversy over new Alzheimer’s drug spell the end for the FDA’s faster approval process?

News

Pink Sheet – FDA’s Pazdur Believes ‘Advanced Research’ Project Could Address Trial ‘Wastefulness’

News

PharmExec.com – FDA’s Pazdur Challenges Attack on Accelerated Approval Program

News

Regulatory Focus – Pazdur mounts defense of accelerated approval during Cures 2.0 panel

News

Pink Sheet – FDA’s Pazdur: Accelerated Approval Is ‘Under Attack,' Supporters Can’t Afford To Remain Silent

News

Bloomberg Law – FDA Cancer Head Defends Path Used for Biogen Alzheimer Approval

News

Politico – Skeptics question if Biden’s new science agency is a breakthrough or more bureaucracy

News

FierceBiotech – CRO ASCO and Friends push for more cancer patients in COVID-19 vaccine trials

News

Bloomberg – Alzheimer’s Drug Discord Puts FDA Accelerated System Under Fire

News

Adaptive Phage Therapeutics – Adaptive Phage Therapeutics Expands Board Following Series B Financing Led by Deerfield Management